Prognostic significance of heat shock protein 70 expression in early gastric carcinoma

Youngran Kang, Woon Yong Jung, Hyunjoo Lee, Wonkyung Jung, Eunjung Lee, Bong Kyung Shin, Aeree Kim, Han Kyeom Kim, Baek-Hui Kim

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Overexpression of heat shock protein 70 (HSP70) has been observed in many types of cancer including gastric adenocarcinomas, although the exact role of HSP70 in carcinogenesis remains unclear. Methods: The study analyzed a total of 458 radical gastrectomy specimens which were immunohistochemically stained with HSP70, p53, and Ki-67 antibodies. Results: The study determined that the expression of HSP70 was significantly increased in early gastric cancer (EGC) compared to advanced gastric cancer (p<0.001). The HSP70 expression was correlated with well-differentiated tumor type, intestinal type of Lauren classification and the lower pT and pN stage. Negative expression of Ki-67 and p53 expression was associated with poor prognosis. The study did not find any correlation between HSP70 and p53 expression. The study determined that HSP70 expression in the EGC subgroup was associated with a poor prognosis (p=0.009), as well as negative Ki-67 expression (p=0.006), but was not associated with p53. Based on multivariate analysis, HSP70 expression (p=0.024), negative expression of Ki-67, invasion depth and lymph node metastasis were determined to be independent prognostic markers. Conclusions: HSP70 is expressed in the early stages of gastric adenocarcinoma. In EGC, HSP70 is a poor independent prognostic marker and is correlated with a low proliferation index.

Original languageEnglish
Pages (from-to)219-226
Number of pages8
JournalKorean Journal of Pathology
Volume47
Issue number3
DOIs
Publication statusPublished - 2013 Aug 27

Fingerprint

HSP70 Heat-Shock Proteins
Stomach
Carcinoma
Stomach Neoplasms
Adenocarcinoma
Gastrectomy
Carcinogenesis
Multivariate Analysis
Lymph Nodes
Neoplasm Metastasis

Keywords

  • Early gastric carcinoma
  • HSP70 heat-shock proteins
  • Ki-67 antigen

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Prognostic significance of heat shock protein 70 expression in early gastric carcinoma. / Kang, Youngran; Jung, Woon Yong; Lee, Hyunjoo; Jung, Wonkyung; Lee, Eunjung; Shin, Bong Kyung; Kim, Aeree; Kim, Han Kyeom; Kim, Baek-Hui.

In: Korean Journal of Pathology, Vol. 47, No. 3, 27.08.2013, p. 219-226.

Research output: Contribution to journalArticle

Kang, Youngran ; Jung, Woon Yong ; Lee, Hyunjoo ; Jung, Wonkyung ; Lee, Eunjung ; Shin, Bong Kyung ; Kim, Aeree ; Kim, Han Kyeom ; Kim, Baek-Hui. / Prognostic significance of heat shock protein 70 expression in early gastric carcinoma. In: Korean Journal of Pathology. 2013 ; Vol. 47, No. 3. pp. 219-226.
@article{87338dd0514a4b279cc2aaf7f47b5b3c,
title = "Prognostic significance of heat shock protein 70 expression in early gastric carcinoma",
abstract = "Background: Overexpression of heat shock protein 70 (HSP70) has been observed in many types of cancer including gastric adenocarcinomas, although the exact role of HSP70 in carcinogenesis remains unclear. Methods: The study analyzed a total of 458 radical gastrectomy specimens which were immunohistochemically stained with HSP70, p53, and Ki-67 antibodies. Results: The study determined that the expression of HSP70 was significantly increased in early gastric cancer (EGC) compared to advanced gastric cancer (p<0.001). The HSP70 expression was correlated with well-differentiated tumor type, intestinal type of Lauren classification and the lower pT and pN stage. Negative expression of Ki-67 and p53 expression was associated with poor prognosis. The study did not find any correlation between HSP70 and p53 expression. The study determined that HSP70 expression in the EGC subgroup was associated with a poor prognosis (p=0.009), as well as negative Ki-67 expression (p=0.006), but was not associated with p53. Based on multivariate analysis, HSP70 expression (p=0.024), negative expression of Ki-67, invasion depth and lymph node metastasis were determined to be independent prognostic markers. Conclusions: HSP70 is expressed in the early stages of gastric adenocarcinoma. In EGC, HSP70 is a poor independent prognostic marker and is correlated with a low proliferation index.",
keywords = "Early gastric carcinoma, HSP70 heat-shock proteins, Ki-67 antigen",
author = "Youngran Kang and Jung, {Woon Yong} and Hyunjoo Lee and Wonkyung Jung and Eunjung Lee and Shin, {Bong Kyung} and Aeree Kim and Kim, {Han Kyeom} and Baek-Hui Kim",
year = "2013",
month = "8",
day = "27",
doi = "10.4132/KoreanJPathol.2013.47.3.219",
language = "English",
volume = "47",
pages = "219--226",
journal = "Journal of Pathology and Translational Medicine",
issn = "2383-7837",
publisher = "Korean Society of Pathologists",
number = "3",

}

TY - JOUR

T1 - Prognostic significance of heat shock protein 70 expression in early gastric carcinoma

AU - Kang, Youngran

AU - Jung, Woon Yong

AU - Lee, Hyunjoo

AU - Jung, Wonkyung

AU - Lee, Eunjung

AU - Shin, Bong Kyung

AU - Kim, Aeree

AU - Kim, Han Kyeom

AU - Kim, Baek-Hui

PY - 2013/8/27

Y1 - 2013/8/27

N2 - Background: Overexpression of heat shock protein 70 (HSP70) has been observed in many types of cancer including gastric adenocarcinomas, although the exact role of HSP70 in carcinogenesis remains unclear. Methods: The study analyzed a total of 458 radical gastrectomy specimens which were immunohistochemically stained with HSP70, p53, and Ki-67 antibodies. Results: The study determined that the expression of HSP70 was significantly increased in early gastric cancer (EGC) compared to advanced gastric cancer (p<0.001). The HSP70 expression was correlated with well-differentiated tumor type, intestinal type of Lauren classification and the lower pT and pN stage. Negative expression of Ki-67 and p53 expression was associated with poor prognosis. The study did not find any correlation between HSP70 and p53 expression. The study determined that HSP70 expression in the EGC subgroup was associated with a poor prognosis (p=0.009), as well as negative Ki-67 expression (p=0.006), but was not associated with p53. Based on multivariate analysis, HSP70 expression (p=0.024), negative expression of Ki-67, invasion depth and lymph node metastasis were determined to be independent prognostic markers. Conclusions: HSP70 is expressed in the early stages of gastric adenocarcinoma. In EGC, HSP70 is a poor independent prognostic marker and is correlated with a low proliferation index.

AB - Background: Overexpression of heat shock protein 70 (HSP70) has been observed in many types of cancer including gastric adenocarcinomas, although the exact role of HSP70 in carcinogenesis remains unclear. Methods: The study analyzed a total of 458 radical gastrectomy specimens which were immunohistochemically stained with HSP70, p53, and Ki-67 antibodies. Results: The study determined that the expression of HSP70 was significantly increased in early gastric cancer (EGC) compared to advanced gastric cancer (p<0.001). The HSP70 expression was correlated with well-differentiated tumor type, intestinal type of Lauren classification and the lower pT and pN stage. Negative expression of Ki-67 and p53 expression was associated with poor prognosis. The study did not find any correlation between HSP70 and p53 expression. The study determined that HSP70 expression in the EGC subgroup was associated with a poor prognosis (p=0.009), as well as negative Ki-67 expression (p=0.006), but was not associated with p53. Based on multivariate analysis, HSP70 expression (p=0.024), negative expression of Ki-67, invasion depth and lymph node metastasis were determined to be independent prognostic markers. Conclusions: HSP70 is expressed in the early stages of gastric adenocarcinoma. In EGC, HSP70 is a poor independent prognostic marker and is correlated with a low proliferation index.

KW - Early gastric carcinoma

KW - HSP70 heat-shock proteins

KW - Ki-67 antigen

UR - http://www.scopus.com/inward/record.url?scp=84882683853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882683853&partnerID=8YFLogxK

U2 - 10.4132/KoreanJPathol.2013.47.3.219

DO - 10.4132/KoreanJPathol.2013.47.3.219

M3 - Article

C2 - 23837014

AN - SCOPUS:84882683853

VL - 47

SP - 219

EP - 226

JO - Journal of Pathology and Translational Medicine

JF - Journal of Pathology and Translational Medicine

SN - 2383-7837

IS - 3

ER -